Results 131 to 140 of about 171,612 (313)
This study presents human in vitro rheumatoid arthritis models using chondrocytes recellularized type II collagen scaffold and 3D‐bioprinted Gelatin‐Matrigel hydrogels with fibroblast‐like synoviocytes, pro‐inflammatory macrophages, and protective barrier macrophages, closely recapitulating key rheumatoid arthritis pathological features.
Huiqun Zhou +6 more
wiley +1 more source
Author Correction: Not marginal but central: type I interferons unleash marginal zone B cells in Sjögren's disease. [PDF]
Werynski A +4 more
europepmc +1 more source
The research demonstrates a Mesenchymal Stem Cell‐inspired microneedle platform (MSCi@MN) that addresses chronic diabetic wounds by combining MSC‐derived extracellular nanovesicles (NV)–DNA conjugates in microneedle tips with photothermal MXene in the patch layer.
Chan Ho Moon +21 more
wiley +1 more source
From Genetic Engineering to Preclinical Safety: A Study on Recombinant Human Interferons. [PDF]
Ramos TI +13 more
europepmc +1 more source
A high‐throughput in vivo mRNA LNP screening platform is developed and employed to screen a large library of 122 mRNA LNPs in vivo for delivery to immune, stromal, and parenchymal cells, identifying promising LNP candidates. A novel small particle flow cytometry‐based protein adsorption analysis method is utilized to interrogate protein corona ...
Alex G. Hamilton +17 more
wiley +1 more source
Role and mechanism of gut microbiota in regulating interferon-mediated programmed cell death in colorectal cancer. [PDF]
Yao Q, Chen S, Qian W, Yang C, Li J.
europepmc +1 more source
Using the convolutional neural network model VDLIN, Co7 is identified as a promising therapeutic candidate. Co7 demonstrates distinct advantages over MCB by effectively balancing anti‐inflammatory and immune‐stimulatory functions, making it a potential novel approach for immune modulation.
Xuefei Guo +6 more
wiley +1 more source
Special Issue: "Innate Immunity to Virus Infection, 2nd Edition". [PDF]
Zhang X, Sun C.
europepmc +1 more source

